Drug Interactions

Filter Standards and Guidance documents

FSRH CEU Guidance: Drug Interactions with Hormonal Contraception (May 2022)

09 May 2022

This FSRH Guidance provides evidence-based recommendations and good practice points for health professionals on drug Interaction with Hormonal Contraception. It is intended for use by health professionals working in sexual and reproductive health, general practice, and obstetric and gynaecology settings.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Guidance: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception (February 2023)

07 February 2023

This FSRH Guidance provides key information and good practice points for health professionals on drug-drug interactions (DDIs) between HIV antiretroviral therapy (ART) and contraception to facilitate the prescription of safe and effective contraception to people living with HIV and on ART.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Response to study: Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme inducing antibiotics and hormonal contraceptives - February 2021

02 February 2021

This statement is a response to a new paper published in BMJ Evidence Based Medicine Journal suggesting that antibiotics may lessen the effectiveness of hormonal contraception.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Statement: St Johns Wort and Hormonal Contraception (March 2014)

01 March 2014

St Johns wort is a herbal product that is used for depressive symptoms and is known to have enzyme-inducing effects on cytochrome p450 enzymes. The MHRA statement highlights that in the last quarter of 2013, two ‘Yellow Card’ reports were received relating to unplanned pregnancies, in women with progestogen-only implants, suspected to be the result of an interaction with St John’s wort.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date